Nutritional Support: The Use of Antioxidants in Inflammatory Bowel Disease.
Sara Jarmakiewicz-CzajaKatarzyna FerencAneta Sokal-DembowskaRafał FilipPublished in: International journal of molecular sciences (2024)
The problem of treating inflammatory bowel disease continues to be a topic of great interest for researchers. Despite the complexity surrounding their treatment and strategies to prolong periods of remission, there is a promising exploration of various compounds that have potential in combating inflammation and alleviating symptoms. Selenium, calcium, magnesium, zinc, and iron are among these compounds, offering a glimpse of hope in the treatment of IBD. These essential minerals not only hold the promise of reducing inflammation in these diseases, but also show the potential to enhance immune function and possibly influence the balance of intestinal microflora. By potentially modulating the gut microbiota, they may help support overall immune health. Furthermore, these compounds could play a crucial role in mitigating inflammation and minimising complications in patients with IBD. Furthermore, the protective effect of these compounds against mucosal damage in IBD and the protective effect of calcium itself against osteoporosis in this group of patients are notable.
Keyphrases
- oxidative stress
- ulcerative colitis
- end stage renal disease
- healthcare
- public health
- newly diagnosed
- chronic kidney disease
- mental health
- human health
- risk assessment
- risk factors
- prognostic factors
- rheumatoid arthritis
- systemic lupus erythematosus
- disease activity
- bone mineral density
- patient reported outcomes
- health information
- social media